APP and Alzheimer disease: ATXN1 (ataxin 1) was screened for one of the candidates associated with AD through a GWAS and functionally validated its loss of function of increased Aβ-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein (Zhang et al. 2010).